Marvell Technology, Inc. Reports Second Quarter of Fiscal Year 2025 Financial Results
Q2 Net Revenue: $1.273 billion, declined by (5)% year-on-year Q2 Gross Margin: 46.2% GAAP gross margin; 61.9% non-GAAP gross margin Q2 Diluted income (loss) per... Read more.
Dell Technologies Delivers Second Quarter Fiscal 2025 Financial Results
News summary Second quarter revenue of $25.0 billion, up 9% year over year Record Infrastructure Solutions Group (ISG) revenue of $11.6 billion, up 38% year over... Read more.
REGENXBIO to Participate in Upcoming Investor Conferences
ROCKVILLE, Md., Aug. 29, 2024 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate the following upcoming investor conferences:... Read more.
Poseida Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, Aug. 29, 2024 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing... Read more.
Congruence Therapeutics Announces Participation in Upcoming Investor Conferences
MONTREAL, Aug. 29, 2024 /PRNewswire/ — Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of correctors for... Read more.
Lam Research Corporation Announces a 15% Increase in Quarterly Dividend
FREMONT, Calif., Aug. 29, 2024 /PRNewswire/ — Lam Research Corporation (Nasdaq: LRCX) today announced that its Board of Directors has approved a $0.30, or... Read more.
MongoDB, Inc. Announces Second Quarter Fiscal 2025 Financial Results
Second Quarter Fiscal 2025 Total Revenue of $478.1 million, up 13% Year-over-Year Continued Strong Customer Growth with Over 50,700 Customers as of July 31, 2024... Read more.
Emeren to Participate at ROTH MKM 11th Annual Solar & Storage Symposium
STAMFORD, Conn., Aug. 29, 2024 /PRNewswire/ — Emeren Group Ltd (“Emeren” or the “Company”) (www.emeren.com) (NYSE: SOL), a leading... Read more.
AUTODESK, INC. ANNOUNCES FISCAL 2025 SECOND QUARTER RESULTS
– Raising the mid-points of billings, revenue, earnings per share, and free cash flow guidance ranges.– Second quarter revenue grew 12 percent, and 13... Read more.
AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
THOUSAND OAKS, Calif., Aug. 29, 2024 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 9:15... Read more.